BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 184 filers reported holding BRIDGEBIO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,551,977 | +315.2% | 665,604 | +170.8% | 0.01% | +400.0% |
| Q2 2023 | $4,227,605 | +475.5% | 245,791 | +454.7% | 0.00% | – |
| Q1 2023 | $734,660 | +119.6% | 44,310 | +0.9% | 0.00% | – |
| Q4 2022 | $334,533 | -21.7% | 43,902 | +2.1% | 0.00% | – |
| Q3 2022 | $427,470 | +7.5% | 43,005 | -1.8% | 0.00% | – |
| Q2 2022 | $397,686 | -13.3% | 43,798 | -3.1% | 0.00% | – |
| Q1 2022 | $458,618 | -49.7% | 45,184 | -17.3% | 0.00% | -100.0% |
| Q4 2021 | $912,000 | -65.4% | 54,664 | -2.8% | 0.00% | -50.0% |
| Q3 2021 | $2,636,000 | -29.6% | 56,236 | -8.5% | 0.00% | -33.3% |
| Q2 2021 | $3,745,000 | +10.8% | 61,436 | +12.0% | 0.00% | 0.0% |
| Q1 2021 | $3,380,000 | +6.6% | 54,873 | +23.0% | 0.00% | 0.0% |
| Q4 2020 | $3,172,000 | +95.7% | 44,603 | +3.2% | 0.00% | +50.0% |
| Q3 2020 | $1,621,000 | +12.1% | 43,213 | -2.6% | 0.00% | +100.0% |
| Q2 2020 | $1,446,000 | +4.8% | 44,367 | -6.8% | 0.00% | -50.0% |
| Q1 2020 | $1,380,000 | +146.0% | 47,602 | +197.4% | 0.00% | +100.0% |
| Q4 2019 | $561,000 | +75.3% | 16,008 | +0.7% | 0.00% | – |
| Q3 2019 | $320,000 | – | 15,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
| M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
| Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
| HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
| Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
| Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
| Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
| HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |